Lung Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Lung Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Autologous Tumor-Infiltrating Lymphocyte (GTE-001 Injection ) for Treatment of Patients With Advanced Lung Adenocarcinoma [Phase 1]
A Phase 1 autologous tumor-infiltrating lymphocyte trial (GTE-001) for advanced lung adenocarcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating a gene-modified immune cell therapy after a conditioning regimen for metastatic melanoma and other metas…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) [Phase 2]
Phase 2 trial update for sotorasib (AMG 510) in KRAS G12C-mutated advanced non-squamous non-small cell lung cancer, highlighting ongoing stu…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Treatment of Multifocal Lung Adenocarcinoma [NA]
This entry notes a Mayo Clinic-sponsored clinical trial for multifocal lung adenocarcinoma. The study status is TERMINATED.
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors [Phase 1, Phase 2]
Phase I/II trial of autologous T cells engineered to express T-cell receptors (TCRs) in patients with solid tumors was terminated with resul…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating bemcentinib in combination with pembrolizumab in advanced non-small cell lung cancer has completed enrollment and p…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: A Study of MORAb-202 in Participants With Previously Treated Metastatic Non-Small Cell Lung Cancer (NSCLC) Adenocarcinoma (AC) [Phase 2]
This is a Phase 2 clinical trial update for MORAb-202 in previously treated metastatic non-small cell lung cancer with adenocarcinoma histol…
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial update reports results from evaluating the combination of sirolimus and auranofin in patients with advanced…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Alaunos Therapeutics reports long-term follow-up data from subjects treated with autologous T cells engineered with a Sleeping Beauty system…
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: CAR T Cells in Mesothelin Expressing Cancers [Phase 1]
Phase 1 study evaluating mesothelin-targeted CAR T cells in mesothelin-expressing cancers; results have been posted for a University of Penn…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors [Phase 2]
Phase 2 study evaluating the efficacy of tislelizumab and spartalizumab across multiple cancers with PD-1 high mRNA expression; the trial is…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: 18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma [NA]
A completed clinical trial evaluated 18F-FDG and 68Ga-FAPI PET/CT imaging in lung adenocarcinoma. The sponsor is The First Affiliated Hospit…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Non-interventional Study for Real-world Data of Afatinib Treatment in First-line Setting and of Subsequent Therapies for Patients With Advanced Epidermal Growth Factor Receptor (EGFR) Mutation-positive Lung Adenocarcinoma
This non-interventional real-world study assesses afatinib as first-line therapy and subsequent treatments in patients with advanced EGFR mu…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor [EARLY_Phase 1]
Early-phase trial of TP53 R248Q-targeted TCR-T cell therapy for advanced solid tumors is not yet recruiting. The trial lists lung adenocarci…
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Intraoperative Frozen Section Pathology to Diagnose the IASLC Grades for Lung Adenocarcinoma (ECTOP-1014)
Completed clinical trial evaluating intraoperative frozen section pathology to diagnose IASLC grades for lung adenocarcinoma (ECTOP-1014). T…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Advanced Lung Tumor Treated by Osimertinib Plus Anlotinib [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the combination of osimertinib and anlotinib for advanced non-small cell lung cancer with EGFR mutations…
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: Cios Mobile 3D Spin for Robotic Bronchoscopy
Clinical trial update indicates the Mayo Clinic-sponsored study evaluating the Cios Mobile 3D Spin for robotic bronchoscopy has completed. T…
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK [Phase 2]
Phase 2 clinical trial update for ALK-rearranged non-small cell lung cancer evaluating pembrolizumab plus bevacizumab and chemotherapy, with…
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: Efficacy and Safety of Tislelizumab Combined With Bevacizumab and Albumin Paclitaxel in Lung Adenocarcinoma [Phase 2]
Phase 2 trial evaluating tislelizumab with bevacizumab and albumin paclitaxel in advanced lung adenocarcinoma (Stage IV) has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019) [Phase 3]
Phase 3 trial evaluating sublobar resection for adenocarcinoma in situ or minimally invasive adenocarcinoma diagnosed by intraoperative froz…
-
CLINICAL_TRIALS trial_result · 2023-09-11Clinical Trial Update: Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018) [Phase 3]
Phase 3 clinical trial investigating selective lymph node dissection for early-stage invasive non-small cell lung cancer (cT1N0M0, CTR>0.5) …
-
CLINICAL_TRIALS trial_result · 2023-07-25Clinical Trial Update: Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib [Phase 2]
A Phase 2 trial evaluated local ablative therapy for oligoprogressive, EGFR-mutated non-small cell lung cancer after treatment with osimerti…
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma (ECTOP-1002) [Phase 2]
Phase 2 trial evaluating pemetrexed and platinum as neoadjuvant therapy for resectable stage II-IVA lung adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Adjuvant Chemotherapy for High Risk Stage I Lung Adenocarcinoma [Phase 2, Phase 3]
A clinical trial update on adjuvant chemotherapy for high-risk stage I lung adenocarcinoma across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION) [Phase 2]
Phase II trial update (VISION) evaluating Tepotinib in advanced non-small cell lung cancer with MET alterations; results were posted in 2023…